需要入住ICU的侵袭性A组链球菌感染:一项全国性、多中心、回顾性研究(ISTRE研究)
该研究在法国37个ICU回顾性纳入222例因侵袭性A组链球菌(iGAS)感染入住ICU的患者,比较新冠疫情前(2018年10月至2019年3月、2019年10月至2020年3月)与疫情后(2022年10月至2023年3月)两个时期。疫情前73例、疫情后149例,病例率分别为205/10万和949/10万ICU入院(p<0.001),疫情后STSS更常见(61% vs 45%,p=0.015)。总体ICU死亡率为19%(疫情前14% vs 疫情后22%,p=0.135)。多因素分析显示有创机械通气、STSS、急性肾损伤、免疫抑制和糖尿病与ICU死亡显著相关。
要点
- 疫情后iGAS感染病例率升至949/10万ICU入院,疫情前为205/10万(p<0.001),升高约4至5倍。
- 疫情后STSS比例高于疫情前(61% vs 45%,p=0.015)。
- 总体ICU死亡率为19%,疫情前14% vs 疫情后22%,差异无统计学显著(p=0.135)。
- 多因素分析中,有创机械通气(OR=6.08,95%CI 1.71-21.60,p=0.005)和STSS(OR=5.75,95%CI 1.71-19.22,p=0.005)与ICU死亡显著相关。
适用人群与场景
- 法国37个ICU收治的因iGAS感染入住ICU的成年患者。
- 两个时期:疫情前为2018年10月至2019年3月及2019年10月至2020年3月,疫情后为2022年10月至2023年3月。
诊断标准与关键阈值
- iGAS感染定义为从正常无菌部位分离出A组链球菌。
- iGAS感染通过国际疾病分类识别,并经各中心微生物实验室数据库确认。
红旗征与不能漏的情况
- STSS:疫情后发生率61%,多因素分析中与ICU死亡显著相关(OR=5.75,95%CI 1.71-19.22,p=0.005)。
研究设计与关键结果
- 研究类型:全国性、多中心、回顾性队列研究,37个法国ICU,共纳入222例因iGAS感染入住ICU的患者。
- 病例数:疫情前73例,疫情后149例。
- 病例率:疫情前205/10万ICU入院 vs 疫情后949/10万ICU入院(p<0.001)。
- STSS:疫情后61% vs 疫情前45%(p=0.015)。
- 病情严重度:中位SOFA评分8(5-13),有创机械通气61%,使用去甲肾上腺素74%。
- ICU死亡率:总体19%,疫情前14% vs 疫情后22%(p=0.135)。
- 多因素分析:有创机械通气(OR=6.08,95%CI 1.71-21.60,p=0.005)、STSS(OR=5.75,95%CI 1.71-19.22,p=0.005)、急性肾损伤(OR=4.85,95%CI 1.05-22.42,p=0.043)、免疫抑制(OR=4.02,95%CI 1.03-15.59,p=0.044)、糖尿病(OR=3.92,95%CI 1.42-10.79,p=0.008)与ICU死亡显著相关。
证据类型、等级与局限
- 证据类型:全国性、多中心、回顾性队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 疫情后iGAS感染入住ICU的病例率较疫情前升高约4至5倍,STSS更常见(61% vs 45%),床旁应关注iGAS感染及STSS的发生。
- 多因素分析提示有创机械通气、STSS、急性肾损伤、免疫抑制和糖尿病与ICU死亡相关(OR分别为6.08、5.75、4.85、4.02、3.92)。
指南或共识出处
- ISTRE研究,发表于Critical Care。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Group A Streptococcus is responsible for severe and potentially lethal invasive conditions requiring intensive care unit (ICU) admission, such as streptococcal toxic shock-like syndrome (STSS). A rebound of invasive group A streptococcal (iGAS) infection after COVID-19-associated barrier measures has been observed in children. Several intensivists of French adult ICUs have reported similar bedside impressions without objective data. We aimed to compare the incidence of iGAS infection before and after the COVID-19 pandemic, describe iGAS patients' characteristics, and determine ICU mortality associated factors.
METHODS: We performed a retrospective multicenter cohort study in 37 French ICUs, including all patients admitted for iGAS infections for two periods: two years before period (October 2018 to March 2019 and October 2019 to March 2020) and a one-year after period (October 2022 to March 2023) COVID-19 pandemic. iGAS infection was defined by Group A Streptococcus isolation from a normally sterile site. iGAS infections were identified using the International Classification of Diseases and confirmed with each center's microbiology laboratory databases. The incidence of iGAS infections was expressed in case rate.
RESULTS: Two hundred and twenty-two patients were admitted to ICU for iGAS infections: 73 before and 149 after COVID-19 pandemic. Their case rate during the period before and after COVID-19 pandemic was 205 and 949/100,000 ICU admissions, respectively (p < 0.001), with more frequent STSS after the COVID-19 pandemic (61% vs. 45%, p = 0.015). iGAS patients (n = 222) had a median SOFA score of 8 (5-13), invasive mechanical ventilation and norepinephrine in 61% and 74% of patients. ICU mortality in iGAS patients was 19% (14% before and 22% after COVID-19 pandemic; p = 0.135). In multivariate analysis, invasive mechanical ventilation (OR = 6.08 (1.71-21.60), p = 0.005), STSS (OR = 5.75 (1.71-19.22), p = 0.005), acute kidney injury (OR = 4.85 (1.05-22.42), p = 0.043), immunosuppression (OR = 4.02 (1.03-15.59), p = 0.044), and diabetes (OR = 3.92 (1.42-10.79), p = 0.008) were significantly associated with ICU mortality.
CONCLUSION: The incidence of iGAS infections requiring ICU admission increased by 4 to 5 after the COVID-19 pandemic. After the COVID-19 pandemic, the rate of STSS was higher, with no significant increase in ICU mortality rate.
参考来源
- Orieux A, Prevel R, Dumery M, et al. Invasive group A streptococcal infections requiring admission to ICU: a nationwide, multicenter, retrospective study (ISTRE study). Crit Care. 2024. PMID: 38167516. doi:10.1186/s13054-023-04774-2
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。